Identification of an imidazopyridine scaffold to generate potent and selective TYK2 inhibitors that demonstrate activity in an in vivo psoriasis model.
Liang, J., Van Abbema, A., Balazs, M., Barrett, K., Berezhkovsky, L., Blair, W.S., Chang, C., Delarosa, D., DeVoss, J., Driscoll, J., Eigenbrot, C., Goodacre, S., Ghilardi, N., MacLeod, C., Johnson, A., Bir Kohli, P., Lai, Y., Lin, Z., Mantik, P., Menghrajani, K., Nguyen, H., Peng, I., Sambrone, A., Shia, S., Smith, J., Sohn, S., Tsui, V., Ultsch, M., Williams, K., Wu, L.C., Yang, W., Zhang, B., Magnuson, S.
Bioorg. Med. Chem. Lett.
